Vaccine Health Literacy Related Text Message Reminders to Increase Receipt of Second Dose of Influenza Vaccine for Young, Low Income, Urban Children
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT01662583 |
|
Recruitment Status :
Completed
First Posted : August 10, 2012
Results First Posted : June 4, 2015
Last Update Posted : August 7, 2015
|
- Study Details
- Tabular View
- Study Results
- Disclaimer
- How to Read a Study Record
| Condition or disease | Intervention/treatment | Phase |
|---|---|---|
| Influenza | Other: Text Message Other: Written reminder | Not Applicable |
| Study Type : | Interventional (Clinical Trial) |
| Actual Enrollment : | 660 participants |
| Allocation: | Randomized |
| Intervention Model: | Parallel Assignment |
| Masking: | Single (Outcomes Assessor) |
| Primary Purpose: | Health Services Research |
| Official Title: | Pragmatic Clinical Trial of Vaccine Health Literacy Related Text Message Reminders to Increase Receipt of Second Dose of Influenza Vaccine for Young, Low Income, Urban Children |
| Study Start Date : | September 2012 |
| Actual Primary Completion Date : | March 2013 |
| Actual Study Completion Date : | June 2013 |
| Arm | Intervention/treatment |
|---|---|
|
Experimental: Educational Text Message
Educational text message reminder
|
Other: Text Message Other: Written reminder |
|
Experimental: Plain Text Message
plain text message reminder
|
Other: Text Message Other: Written reminder |
|
Written reminder only
written reminder at time of vaccination
|
Other: Written reminder |
- Receipt of 2nd Dose of the Influenza Vaccine. [ Time Frame: by April 30th after receipt of first dose (up to 8 months) ]
- Number of Subjects Who Receive the 2nd Dose of the Influenza Vaccine on Time. [ Time Frame: by 42 days after dose of first vaccination ]
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 6 Months to 9 Years (Child) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Parenting adult of child age 6 months through 8 years
- Child receives care at study site (visit in last 12 mths)
- child received influenza vaccine and needs a second this season
- Parent has cell phone has text message capability
- Parent speak English or Spanish
- Can read text messages
Exclusion Criteria:
- Parent does not speak English or Spanish
- Parent does not have cell phone with text messages
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01662583
| United States, New York | |
| Columbia University | |
| New York, New York, United States, 10032 | |
| Principal Investigator: | Melissa Stockwell, MD MPH | Columbia University |
| Responsible Party: | Melissa Stockwell, MD, MPH, Assistant Professor of Pediatrics and Population and Family Health, Columbia University |
| ClinicalTrials.gov Identifier: | NCT01662583 |
| Other Study ID Numbers: |
AAAJ9354 |
| First Posted: | August 10, 2012 Key Record Dates |
| Results First Posted: | June 4, 2015 |
| Last Update Posted: | August 7, 2015 |
| Last Verified: | July 2015 |
|
Influenza text message vaccination |
|
Influenza, Human Respiratory Tract Infections Infections Orthomyxoviridae Infections |
RNA Virus Infections Virus Diseases Respiratory Tract Diseases |

